Excito-repellent and Pesticide-Likeness Properties of Essential Oils on Carpophilus dimidiatus (Fabricius) (Nitidulidae) and Oryzaephilus mercator (L.) (Silvanidae).

Carpophilus dimidiatus (Fabricius) (Nitidulidae) and Oryzaephilus mercator (L.) (Silvanidae) are insect pests that cause severe damage in important walnut growing regions in the northwest of Argentina. The current management approaches for these pests involve the use of unsafe phosphorus pesticides whose overuse have led to farmworker poisoning, pest resistance issues, and environmental contamination. Plant extracts, particularly essential oils, are an alternative source of insect control agents. Excito-repellent essential oils can be used to develop ecofriendly tools for managing the pest population without affecting quality and visual appearance of the stored walnuts. Laboratory studies were conducted to assess the excito-repellent effects of C. dimidiatus and O. mercator of 12 essential oils derived from aromatic plants used as food additives and traditional medicine in Argentina: Aloysia citrodora (AC), Aloysia gratissima (AG), Aloysia gratissima var. Gratissima (AGG), Blepharocalyx salicipholius (BS), Hyptis mutabilis (HM), Lippia junelliana (LJ), Lippia turbinata (LT), Mentha x piperita (MP), Minthostachys mollis (MM), Minthostachys verticillata (MV), Origanum vulgare(OV), and Rosmarinus officinalis (RO). The most bioactive EOs (ERijk ≥ 70%) were Aloysia gratissima var. Gratissima (AGG), Minthostachys verticillata, and Lippia junelliana. Their bioactivity profile and chemical space, characterized from GC-MS measures, Generalized Estimating Equations, and Hierarchical Cluster Analysis, revealed that they are mixtures of very functionalized molecules with physicochemical properties similar to those of insecticides with low residual property that enter the insect body through the respiratory system by inhalation. The AGG, MV, and LJ oils are promising as protective agents of walnut products. In our laboratory, studies of their formulations for use in integrated pest management programs are still ongoing.

CryoEM reveals that ribosomes in microsporidian spores are locked in a dimeric hibernating state.

Translational control is an essential process for the cell to adapt to varying physiological or environmental conditions. To survive adverse conditions such as low nutrient levels, translation can be shut down almost entirely by inhibiting ribosomal function. Here we investigated eukaryotic hibernating ribosomes from the microsporidian parasite Spraguea lophii in situ by a combination of electron cryo-tomography and single-particle electron cryo-microscopy. We show that microsporidian spores contain hibernating ribosomes that are locked in a dimeric (100S) state, which is formed by a unique dimerization mechanism involving the beak region. The ribosomes within the dimer are fully assembled, suggesting that they are ready to be activated once the host cell is invaded. This study provides structural evidence for dimerization acting as a mechanism for ribosomal hibernation in microsporidia, and therefore demonstrates that eukaryotes utilize this mechanism in translational control.

Insertion Torque and Resonance Frequency Analysis in Tapered and Parallel Dental Implants.

Primary implant stability (PIS) is known to vary with recipient bone mass and density, dental implant design and surgical technique. The objective of this preliminary study was to compare rotational and lateral PIS of same-coronal-diameter conical and parallel implants, using insertion torque recorded with a dental implant motor set and implant stability quotient obtained from resonance frequency analysis (performed with both Osstell and Penguin systems) as measures of rotational and lateral stability, respectively. Additionally, the relationship between PIS and alveolar ridge width (ARW) was explored in both implant types. Sixty dental implants (30 tapered and 30 parallel) were randomly placed with a split-mouth design in 17 patients. Bone density and ARW were estimated from cone beam computed tomography images taken with radiological-surgical templates. Density and width values were similar in the 2 groups (P > .05). Implant coronal diameters were 3.75 mm in all cases, while consistent with the manufacturer's recommendations, final drill bit diameters used were 3.25 and 3.4 mm for parallel and tapered implants, respectively. Insertion torque was higher (P < .05) with parallel implants, but between-group differences in implant stability quotient were not significant (P > .05). In tapered implants, insertion torque was inversely correlated with ARW (P < .001). Notably, significant differences were observed between resonance frequency analysis values from Osstell and Penguin systems (P < .001). In conclusion, future studies should explore how PIS may be influenced by final drill bit size regardless of implant design and potential limits on the effectiveness of tapered implants to achieve good stability in thick low-density bone.

ALL-RIC trial protocol: a comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission.

INTRODUCTION: The usage of a T-cell depleted, reduced intensity conditioning (RIC) approach to haematopoietic cell transplantation (HCT) in adult patients with acute lymphoblastic leukaemia (ALL) over 40 years of age and in first complete remission (CR) has resulted in encouraging rates of event-free and overall survival in a population of adults with high risk disease. However, relapse rates remain high-with disease progression being the major cause of treatment failure. Using different, more powerful conditioning approaches is the logical next step in examining the role of RIC allogeneic HCT in adult ALL. METHODS AND ANALYSIS: The ALL-RIC trial is a two-arm, phase II, multicentre, randomised clinical trial in adult patients with ALL in first or second CR, who are undergoing allogeneic HCT. Comparison of a novel RIC transplant conditioning regimen using reduced-dose total body irradiation (TBI), cyclophosphamide and alemtuzumab, is made against a standardised RIC approach using fludarabine, melphalan and alemtuzumab. The primary outcome of the study is disease-free survival at 3 years, defined as time from randomisation to the first of either relapse or death from any cause. Patients who are still alive and progression-free at the end of the trial will be censored at their last date known to be alive. Secondary outcomes include overall survival and non-relapse mortality. ETHICS AND DISSEMINATION: The protocol was approved by the East Midlands-Leicester Central Research Ethics committee (18/EM/0112). Initial approval was received on 12 June 2018. Current protocol version (V.6.0) approval obtained on 18 November 2019. The Medicines and Healthcare products Regulatory Agency (MHRA) also approved all protocol versions. The results of this trial will be disseminated through national and international presentations and peer-reviewed publications. TRIAL REGISTRATION NUMBER: EudraCT Number: 2017-004800-23.ISRCTN99927695.

Optimised conformal total body irradiation: a heterogeneous practice, so where next?

The use of volumetric arc therapy and inverse planning has been in routine use in radiotherapy for two decades. However, use in total body irradiation (TBI) has been more recent and few guidelines exist as to how to plan or verify. This has led to heterogeneous approaches. The goal of this review is to provide an overview of current advanced planning and dosimetry verification protocols used in optimised conformal TBI as a basis for investigating the need for greater standardisation in TBI.

Otitis externa maligna. Experiencia a lo largo de 25 años en un hospital de tercer nivel / Malignant external otitis. Experience over 25 years at a tertiary referral hospital

Introducción y objetivo: La otitis externa maligna (OEM) es una infección agresiva de los tejidos blandos del oído externo y estructuras circundantes, que puede diseminarse e involucrar la base del cráneo y la articulación temporomandibular (ATM). Afecta fundamentalmente a pacientes inmunodeprimidos mayores de 65 años. El objetivo de este trabajo ha sido conocer las características de los pacientes diagnosticados de OEM en nuestro hospital durante los últimos años y establecer los criterios diagnóstico-terapéuticos de esta rara enfermedad. Método: Se realizó un estudio descriptivo, observacional y retrospectivo, de los pacientes ingresados en el Hospital Clínico Universitario de Valladolid por OEM entre los años 1996 y 2021. Resultados: En los últimos 25 años fueron ingresados por OEM nueve pacientes, 78% varones (7/9) y con una edad media de 76,8 años. Todos manifestaron precozmente la enfermedad, con otalgia, otorrea y tejido de granulación en el conducto auditivo externo (CAE). Ninguno tuvo afectación de pares craneales, pero cuatro sufrieron invasión de la ATM y dos fallecieron. Discusión y Conclusiones: Actualmente el diagnóstico de OEM se establece a partir de una variedad de hallazgos clínicos, de laboratorio y radiográficos. El tratamiento antibiótico depende de la severidad de la infección. Desde la aparición de los antibióticos antipseudomónicos, el tratamiento quirúrgico inicial de esta patología no está indicado, realizándose únicamente biopsia o desbridamiento para el diagnóstico diferencial con patología tumoral. Conclusión: La OEM continúa siendo una enfermedad con grave morbilidad y potencialmente mortal, especialmente en pacientes ancianos y con otras comorbilidades. (AU)

Introduction and objective: Malignant external otitis (MEO) is an aggressive infection of the soft tissues of the external canal and surrounding structures, which can spread and involve the skull base and the temporomandibular joint (TMJ). It mainly affects immunocompromised patients over 65 years of age. The objective of this study has been to know the characteristics of patients diagnosed with MEO in our hospital in recent years and to establish the diagnosis and therapeutic criteria for this rare disease. Method: A descriptive, observational, and retrospective study of patients diagnosed with MEO at the University Clinical Hospital (Valladolid, Spain) between 1996 and 2021 was carried out. Results: Nine patients were diagnosed with MEO in the last 25 years, 78% male (7/9), and with a mean age of 76.8 years. All patients manifested the disease early with otalgia, otorrhea and granulation tissue in the external auditory canal (EAC). None had cranial nerve involvement, but four had TMJ invasion and two of the nine patients in the sample died. Discussion: Currently the diagnosis of MEO is established from a variety of clinical, laboratory and radiographic findings. Antimicrobial therapy depends on the severity of the infection. Since the availability of systemic antipseudomonal antibiotics, surgical treatment of this pathology is not indicated initially, performing only biopsy or debridement for differential diagnosis with tumor pathology. Conclusion: MEO continues to be a disease with serious morbidity and maximum mortality, especially in elderly patients and with other comorbidities. (AU)

Effectiveness, Toxicity, and Survival Predictors of Regorafenib in Metastatic Colorectal Cancer: A Multicenter Study of Routinely Collected Data.

OBJECTIVES: To assess the effectiveness and toxicity of regorafenib in patients with metastatic colorectal cancer (mCRC) in routine clinical practice, as well as predictive factors of effectiveness. METHODS: This was a retrospective multicenter study in patients with mCRC who received regorafenib from November 2013 to May 2020. Effectiveness was evaluated by overall survival (OS) and progression-free survival (PFS) using the Kaplan-Meier method. Cox regression was performed to determine survival predictors. RESULTS: Ninety patients were enrolled (median age, 64.3 years). Fifty-two patients (57.8%) were male, and 57 (63.3%) had an ECOG performance status (PS) of 0 to 1. Median follow-up was 2.80 months. Median OS was 8.03 months (95% CI, 5.90-10.17), and median PFS was 2.90 months (95% CI, 2.59-3.21). Eighty-eight patients (97.8%) experienced drug-related adverse events. The most frequent were fatigue in 66 patients (73.3%), followed by palmar-plantar erythrodysesthesia in 40 (44.4%). Low liver tumor burden score (LTBS) and good ECOG PS were independent OS predictive factors. CONCLUSIONS: Patients taking regorafenib had OS and PFS rates similar to those reported in previous randomized trials; the agent had a poor toxicity profile. We identified low LTBS and good ECOG PS as possible predictive factors of better OS, useful in selecting patients with mCRC who might benefit from regorafenib.

SEAFARER - A new concept for validating radiotherapy patient specific QA for clinical trials and clinical practice.

BACKGROUND: The quality of radiotherapy delivery has been shown to significantly impact clinical outcomes including patient survival. To identify errors, institutions perform Patient Specific Quality Assurance (PSQA) assessing each individual radiotherapy plan prior to starting patient treatments. Externally administered Dosimetry Audits have found problems despite institutions passing their own PSQA. Hence a new audit concept which assesses the institution's ability to detect errors with their routine PSQA is needed. METHODS: Purposefully introduced edits which simulated treatment delivery errors were embedded into radiation treatment plans of participating institutions. These were designed to produce clinically significant changes yet were mostly within treatment delivery specifications. Actual impact was centrally assessed for each plan. Institutions performed PSQA on each plan, without knowing which contained errors. RESULTS: Seventeen institutions using six radiation treatment planning systems and two delivery systems performed PSQA on twelve plans each. Seventeen erroneous plans (across seven institutions) passed PSQA despite causing >5% increase in spinal cord dose relative to the original plans. Six plans (from four institutions) passed despite a >10% increase. CONCLUSIONS: This novel audit concept evolves beyond testing an institution's ability to deliver a single test case, to increasing the number of errors caught by institutions themselves, thus increasing quality of radiation therapy and impacting every patient treated. Administered remotely this audit also provides advantages in cost, environmental impact, and logistics.

Tricofoliculoma del conducto auditivo externo. Revisión bibliográfica / Trichofolliculoma in the external auditory canal. Bibliographic review

Introducción y objetivo: El tricofoliculoma es un tumor anexial de los folículos pilosos que excepcionalmente puede presentarse en el conducto auditivo externo. El objetivo de este artículo es revisar la bibliografía publicada sobre el tricofoliculoma localizado en el conducto auditivo externo a propósito de un caso diagnosticado en nuestro centro. Método: Revisión bibliográfica por dos revisores independientes en mayo 2020 en bases de datos actualizadas. Resultados: En la literatura se hallaron seis casos clínicos publicados de tricofoliculoma en conducto auditivo externo. Conclusiones: El diagnóstico histológico de tricofoliculoma de conducto auditivo externo. (AU)

Introduction and objective: Trichofoliculoma is an adnexal tumor of the hair follicles that may exceptionally occur in the external auditory canal. The objective of this article is to review the published literature on trichofoliculoma located in the external auditory canal about a case diagnosed in our center. Method: Literature review by two independent reviewers in May 2020 in updated databases. Results: In the literature, six published clinical cases of trichofoliculoma in the external auditory canal were found. Conclusions: The histological diagnosis of trichofoliculoma of the external auditory canal. (AU)

Tricofoliculoma del conducto auditivo externo. Un caso excepcional de presentación agresiva / Trichofolliculoma of the external auditory canal, an exceptional case of aggressive presentation

Introducción: El tricofoliculoma es una tumoración anexial, infrecuente y benigna, de los folículos pilosos, cuya localización en el conducto auditivo externo (CAE) es excepcional. Objetivo: Describir y actualizar, las características clínicas y evolutivas del tricofoliculoma del CAE a través de un caso clínico. Caso clínico: Mujer de 47 años con una tumoración agresiva del CAE, que destruía la mastoides, cuyo estudio histopatológico, tras la cirugía, ofreció el diagnóstico de tricofoliculoma, asociado a un colesteatoma, Discusión y conclusiones: El tricofoliculoma es un raro tumor de los folículos pilosos, cuya localización en el CAE es excepcional. El comportamiento agresivo del caso presentado quizá fuera debido a su asociación con un colesteatoma, de probable origen secundario. (AU)

Introduction and objective: Trichofolliculoma is a rare and benign adnexal tumour of the hair follicles. The location of this tumour in the external auditory canal (EAC) is exceptional. Its diagnosis is histopathological. Objective: Present an exceptional clinical case, the finding of a trichofolliculoma in the external auditory canal. Clinical case: We present the clinical case of a CAE trichofolliculoma that, when associated with a cholesteatoma, had an aggressive manifestation with destruction of the temporal bone. Conclusion: Trichofolliculoma is a rare tumour of the hair follicles whose location in the EAC is exceptional. The aggressive behaviour of the case presented was due to its association with a cholesteatoma, probably secondary to the obstruction and recurrent inflammatory processes of the tumour. (AU)

Predicted Risks of Cardiovascular Disease Following Chemotherapy and Radiotherapy in the UK NCRI RAPID Trial of Positron Emission Tomography-Directed Therapy for Early-Stage Hodgkin Lymphoma.

PURPOSE: The contemporary management of early-stage Hodgkin lymphoma (ES-HL) involves balancing the risk of late adverse effects of radiotherapy against the increased risk of relapse if radiotherapy is omitted. This study provides information on the risk of radiation-related cardiovascular disease to help personalize the delivery of radiotherapy in ES-HL. METHODS: We predicted 30-year absolute cardiovascular risk from chemotherapy and involved field radiotherapy in patients who were positron emission tomography (PET)-negative following three cycles of doxorubicin, bleomycin, vinblastine, and dacarbazine chemotherapy within a UK randomized trial of PET-directed therapy for ES-HL. Cardiac and carotid radiation doses and chemotherapy exposure were combined with established dose-response relationships and population-based mortality and incidence rates. RESULTS: Average mean heart dose was 4.0 Gy (range 0.1-24.0 Gy) and average bilateral common carotid artery dose was 21.5 Gy (range 0.6-38.1 Gy), based on individualized cardiovascular dosimetry for 144 PET-negative patients receiving involved field radiotherapy. The average predicted 30-year radiation-related absolute excess overall cardiovascular mortality was 0.56% (range 0.01%-6.79%; < 0.5% in 67% of patients and > 1% in 15%), whereas average predicted 30-year excess incidence was 6.24% (range 0.31%-31.09%; < 5% in 58% of patients and > 10% in 24%). For cardiac disease, the average predicted 30-year radiation-related absolute excess mortality was 0.42% (0.79% with mediastinal involvement and 0.05% without) and for stroke, it was 0.14%. CONCLUSION: Predicted excess cardiovascular risk is small for most patients, so radiotherapy may provide net benefit. However, for a minority of patients receiving high doses of radiation to cardiovascular structures, it may be preferable to consider advanced radiotherapy techniques to reduce doses or to omit radiotherapy and accept the increased relapse risk. Individual assessment of cardiovascular and other risks before treatment would allow personalized decision making about radiotherapy in ES-HL.

Medicago truncatula Yellow Stripe-Like7 encodes a peptide transporter participating in symbiotic nitrogen fixation.

Yellow Stripe-Like (YSL) proteins are a family of plant transporters that are typically involved in transition metal homeostasis. Three of the four YSL clades (I, II and IV) transport metals complexed with the non-proteinogenic amino acid nicotianamine or its derivatives. No such capability has been shown for any member of clade III, but the link between these YSLs and metal homeostasis could be masked by functional redundancy. We studied the role of the clade III YSL protein MtSYL7 in Medicago truncatula nodules. MtYSL7, which encodes a plasma membrane-bound protein, is mainly expressed in the pericycle and cortex cells of the root nodules. Yeast complementation assays revealed that MtSYL7 can transport short peptides. M. truncatula transposon insertion mutants with decreased expression of MtYSL7 had lower nitrogen fixation rates and showed reduced plant growth whether grown in symbiosis with rhizobia or not. YSL7 mutants accumulated more copper and iron in the nodules, which is likely to result from the increased expression of iron uptake and delivery genes in roots. Taken together, these data suggest that MtYSL7 plays an important role in the transition metal homeostasis of nodules and symbiotic nitrogen fixation.

Self-setup of home respiratory polygraphy for the diagnosis of sleep apnea syndrome: cost-efficiency study.

PURPOSE: To evaluate the differences in reliability and costs of home respiratory polygraphy (HRP) when installed by the patient and by a nurse, in order to determine the factors affecting and to consider the possible generalization of self-setup procedure. Several HRP devices have been validated for obstructive sleep apnea (OSA) diagnosis but convenience of a nurse intervention in HRP installation has been scarcely studied. METHODS: This is a prospective and interventional study. About 301 participants were assigned to 2 groups: self-setup and nurse intervention. Sleep study, questionnaires, and diagnostic procedures were performed following the clinical practice in 2016. Signals were considered lost above 3 min, and success of the test was established according to guidelines. Costs were calculated according to a previous multicenter study. RESULTS: Both groups (self-setup and nurse intervention) resulted homogeneous in age, gender, BMI, and final diagnosis of OSA. Signal losses during the test were similar in both groups. Slightly higher percentage of unsuccessful tests were obtained in the self-setup procedure (5.3 vs 2.0%, p = 0.121). The costs were similar (107 vs 105 €) in the self-setup group as compared to the nurse setup group. CONCLUSIONS: The setup of HRP by either the patient or nurse had similar costs and data acquisition. Both installation procedures of HRP were similar regarding test reliability and costs. Main findings are that self-installation by the patient could be similarly reliable and economic as installation by a nurse, as far as consensus guidelines are followed. This study demonstrates that self-setup of HRP is a potentially viable option for the diagnosis of OSA.

Treatment of classical Hodgkin lymphoma in young adults aged 18-30 years with a modified paediatric Hodgkin lymphoma protocol. Results of a multicentre phase II clinical trial (CRUK/08/012).

This phase II trial was designed to determine the safety and efficacy of a modified paediatric risk-stratified protocol in young adults (18-30 years) with classical Hodgkin Lymphoma. The primary end-point was neurotoxicity rate. The incidence of grade 3 neurotoxicity was 11% (80% CI, 5-19%); a true rate of neuropathy of >15% cannot be excluded. Neuropathy and associated deterioration in quality of life was largely reversible. The overall response rate was 100% with 40% complete remission (CR) rate. Twelve months disease-free survival (DFS) was 91%. We demonstrate that a risk-stratified paediatric combined modality treatment approach can be delivered to young adults without significant irreversible neuropathy.

Colesteatoma de conducto auditivo externo: estudio de una serie de casos / Cholesteatoma of the external auditory canal: case series study

INTRODUCCIÓN Y OBJETIVOS: El colesteatoma de conducto auditivo externo (CCAE) es un proceso patológico poco frecuente, caracterizado por la invasión de tejido escamoso en un área del canal auditivo, que progresa hasta la destrucción ósea. Debido a la escasez de casos publicados hemos considerado de utilidad esta revisión. MATERIAL Y MÉTODOS: Estudio prospectivo y observacional desde el año 2000, de 18 pacientes diagnosticados clínicamente de CCAE en nuestro servicio de ORL. RESULTADOS: El porcentaje de hombres y mujeres es similar, con una edad media de diagnóstico de 60 años. La localización más frecuente es póstero-inferior y en la mayor parte de casos el origen es primario. La otalgia, la otorrea y la hipoacusia fueron los síntomas principales, siendo menos habitual el prurito y excepcional la debilidad facial. En general el tratamiento es conservador, pero resultó necesario el abordaje quirúrgico en un tercio de pacientes mediante canaloplastia, siguiendo el esquema expuesto, o la mastoidectomía, en función de la extensión de las lesiones. CONCLUSIONES: Aunque desconocemos los mecanismos patogénicos responsables de la formación y desarrollo del CCAE, la inclusión de queratina entre el epitelio y el hueso, con la participación del periostio, parecen ser los desencadenantes del proceso. El diagnóstico es clínico y su extensión determina el empleo de un tratamiento local o quirúrgico, que suele ser resolutivo

INTRODUCTION: External auditory canal cholesteatoma (EACC) is a rare entity characterized by the invasion of squamous tissue in the auditory canal, that progresses to bone destruction. Due to the scarcity of published cases of EACC, we have deemed useful this review. MATERIAL AND METHODS: Prospective and observational study from the year 2000 to the present in 18 patients clinically diagnosed with EACC in our ORL service. RESULTS: The percentage of men and women is similar, with a mean age at diagnosis of 60 years. The most frequently location was postero-inferior, and in most cases, the origin is primary. Otalgia, otorrhea and subjective hearing loss were the main symptoms, being less common the pruritus and exceptional facial weakness. Overall, the treatment is conservative, but it was necessary surgical treatment on one-third of the patients, performing canaloplasty or mastoidectomy, according to the extent of injuries. CONCLUSIONS: Although we do not know the genesis and pathogenic mechanisms responsible of EACC formation and development, the inclusion of keratin between the epithelium and bone, with the participation of the periosteum, seems to be the trigger of this process. The diagnosis is clinical, and its extension determines the use of a local or surgical treatment, which is usually resolutive

MtMOT1.2 is responsible for molybdate supply to Medicago truncatula nodules.

Symbiotic nitrogen fixation in legume root nodules requires a steady supply of molybdenum for synthesis of the iron-molybdenum cofactor of nitrogenase. This nutrient has to be provided by the host plant from the soil, crossing several symplastically disconnected compartments through molybdate transporters, including members of the MOT1 family. Medicago truncatula Molybdate Transporter (MtMOT) 1.2 is a Medicago truncatula MOT1 family member located in the endodermal cells in roots and nodules. Immunolocalization of a tagged MtMOT1.2 indicates that it is associated to the plasma membrane and to intracellular membrane systems, where it would be transporting molybdate towards the cytosol, as indicated in yeast transport assays. Loss-of-function mot1.2-1 mutant showed reduced growth compared with wild-type plants when nitrogen fixation was required but not when nitrogen was provided as nitrate. While no effect on molybdenum-dependent nitrate reductase activity was observed, nitrogenase activity was severely affected, explaining the observed difference of growth depending on nitrogen source. This phenotype was the result of molybdate not reaching the nitrogen-fixing nodules, since genetic complementation with a wild-type MtMOT1.2 gene or molybdate-fortification of the nutrient solution, both restored wild-type levels of growth and nitrogenase activity. These results support a model in which MtMOT1.2 would mediate molybdate delivery by the vasculature into the nodules.

QSAR Study of Biologically Active Essential Oils against Beetles Infesting the Walnut in Catamarca, Argentina.

Essential oils from six species of aromatic plants collected in the Catamarca Province of Argentina were evaluated for their chemical composition and repellent and insecticidal activities against beetles of the genus Carpophilus (Coleoptera: Nitidulidae) and Oryzaephilus (Coleoptera: Silvanidae) that infest the local walnut production. Experimental data were analyzed using generalized estimating equations, with normal distribution and the identity link function. From the spectral information from the tested essential oils, we worked their molecular modeling as mixtures by developing mixture descriptors ( Dmix) that combined the molecular descriptor of each component in the mixture ( d i) and its relative concentration ( x i), i.e., Dmix = f( d i, x i). The application of chemoinformatic approaches determined that a combination of mixture descriptors related to molecular size, branchedness, charge distribution, and electronegativity were useful to explain the bioactivity profile against Carpophilus spp. and Oryzaephilus spp. The reported models were rigorously validated using stringent statistical parameters and essential oils reported with repellent activity against other beetle species from the Nitidulidae and Silvanidae families. This model confirmed each essential oil as a repellent with a comparable performance to the experimental reports.

MtMTP2-Facilitated Zinc Transport Into Intracellular Compartments Is Essential for Nodule Development in Medicago truncatula.

Zinc (Zn) is an essential nutrient for plants that is involved in almost every biological process. This includes symbiotic nitrogen fixation, a process carried out by endosymbiotic bacteria (rhizobia) living within differentiated plant cells of legume root nodules. Zn transport in nodules involves delivery from the root, via the vasculature, release into the apoplast and uptake into nodule cells. Once in the cytosol, Zn can be used directly by cytosolic proteins or delivered into organelles, including symbiosomes of infected cells, by Zn efflux transporters. Medicago truncatula MtMTP2 (Medtr4g064893) is a nodule-induced Zn-efflux protein that was localized to an intracellular compartment in root epidermal and endodermal cells, as well as in nodule cells. Although the MtMTP2 gene is expressed in roots, shoots, and nodules, mtp2 mutants exhibited growth defects only under symbiotic, nitrogen-fixing conditions. Loss of MtMTP2 function resulted in altered nodule development, defects in bacteroid differentiation, and severe reduction of nitrogenase activity. The results presented here support a role of MtMTP2 in intracellular compartmentation of Zn, which is required for effective symbiotic nitrogen fixation in M. truncatula.

Exploring the dimensionality and the psychometric properties of the TRIM-18 in the Spanish context / Exploración de la dimensionalidad y de las propiedades psicométricas del TRIM-18 en contexto Español

Introduction: The Transgression-Related Interpersonal Motivations Inventory (TRIM-18) is an instrument that assesses episodic forgiveness composed of three subscales: avoidance, revenge and benevolence. In the present study we examined the dimensionality of the Spanish version of the TRIM-18 (TRIM-18-S). We provided evidences of estimated reliability and construct validity of the interpretation of the scores. Method: A total of 943 participants completed the TRIM-18-S. A subset of 94 participants completed the measure again to allow computation of two-week estimated temporal stability, and 277 participants completed additional measures of empathy, anger, and information regarding the relation with the offender to allow computations supporting construct validity. Results: The TRIM-18-S showed good psychometric properties. Confirmatory factor analysis revealed a three-factor structure. Alphas ranged from .80 to .90. Two week estimated test-retest correlations ranged from .74 to .84. Construct validity was supported by correlations with a single-item measuring forgiveness and with empathy, state anger, and closeness and type of relationship. Conclusions: The scale presents adequate psychometric properties for its potential use in Spanish population (AU)

Introducción: La escala Transgression-Related Interpersonal Motivations (TRIM-18) es un instrumento diseñado para evaluar perdón específico compuesto por tres subescalas: evitación, venganza y benevolencia. En el presente estudio se examina la dimensionalidad de la versión española del TRIM-18 (TRIM-18-S). Se presentan evidencias de fiabilidad y de validez de constructo de la interpretación de las puntuaciones. Método: Un total de 943 sujetos completaron el TRIM-18-S. Una submuestra de 94 participantes completaron la escala otra vez dos semanas después para el cálculo de la estabilidad temporal, y 277 participantes completaron medidas adicionales de empatía, ira e información relacionada con el tipo de ofensor para el cálculo de la validez de constructo. Resultados: El TRIM-18-S mostró buenas propiedades psicométricas. El análisis factorial confirmatorio reveló una estructura tridimensional. Los valores del alfa de Cronbach variaron entre .80 y .90. Los valores obtenidos para la fiabilidad test-retest variaron entre.74 y .84. Se hallaron evidencias de validez de constructo a partir de las correlaciones con el ítem único de medida de perdón y con empatía, ira, cercanía con el ofensor y tipo de relación. Conclusiones: La escala presenta propiedades psicométricas adecuadas para su uso en población español (AU)